Medicine, Media & Patients: A New Professional Language

Panel Convened  at Annual Medical conference at NIAF Scientists, journalists and cancer patients gathered to discuss the importance of precision medicine and accurate health and science communication during the National Italian American Foundation’s (NIAF) 44th Anniversary Gala Weekend in Washington, D.C. “Medicine, Media, and Patients,” presented by Sbarro Health Research Organization (SHRO), included updates on … Continue reading Medicine, Media & Patients: A New Professional Language

SHRO Founder Presented with Career Award and Appointed Chair of Italian Cancer Association FONICAP

Sbarro Health Research Organization founder and Director, Antonio Giordano, M.D., Ph.D., has been recognized with a career award "for the great contributions he has made and which he will continue to make to science, medicine and research." Giordano is director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University as well … Continue reading SHRO Founder Presented with Career Award and Appointed Chair of Italian Cancer Association FONICAP

Adding local anesthetics can improve treatment for incurable breast cancer, melanoma

A new study examined the effects of local anesthetics combined with standard chemotherapy for treatment of incurable triple-negative (TN) breast cancer, as well as melanoma. The results suggest that the combined treatment can lower the effective chemotherapy dosage, reduce side effects, improve tumor cell apoptosis, and reduce tumor cell migration. Researchers at the Sbarro Health … Continue reading Adding local anesthetics can improve treatment for incurable breast cancer, melanoma

Untreatable Olive Tree Disease Can Be Contained, But Must Be Better Monitored, says SHRO Researcher

  Xylella fastidiosa, subsp. pauca is a bacterial pathogen currently devastating the olive orchards in Southern Italy (Apulia). Due to the epidemic, local production of olive oil has dropped by 90%, olive mills are shut down, the regional economy is suffering, and an invaluable cultural asset is compromised. Keeping the epidemic under control requires the identification of … Continue reading Untreatable Olive Tree Disease Can Be Contained, But Must Be Better Monitored, says SHRO Researcher

Genetic Profiling and Personalized Training: Study Published in Collaboration between U.S. Researchers and the Medical Staff of the SSC Napoli

A study recently published in the international scientific Journal of Cellular Physiology is the result of a collaboration between the Sbarro Health Research Organization (SHRO), a team of Italian researchers, and the Medical Staff of the SSC Napoli, one of the leading soccer clubs in Italy’s Serie A league. The article, "Genomic analysis reveals association of … Continue reading Genetic Profiling and Personalized Training: Study Published in Collaboration between U.S. Researchers and the Medical Staff of the SSC Napoli

Oncolytic Viruses Against Mesothelioma: A Possible Weapon to Shrink Cancer and Boost the Antitumoral Immune Response

Mesothelioma is a deadly cancer mainly caused by exposure to asbestos or other toxic mineral fibers. Currently, there is no effective cure against this disease and life expectancy of patients with mesothelioma remains very low. Virotherapy, which is based on the use of viruses to fight cancer cells, has long been investigated as a possible … Continue reading Oncolytic Viruses Against Mesothelioma: A Possible Weapon to Shrink Cancer and Boost the Antitumoral Immune Response

Regulation of Cancer Promoting Molecule EphB4 Offers Potential Treatment Target for Mesothelioma, Other Cancers

A novel cancer-promoting molecular mechanism has been discovered by Pierluigi Scalia, M.D., Ph.D., with his co-workers at the Sbarro Institute for Cancer Research and Molecular Medicine, Division of Biology, Temple University, the Department of Medical Biotechnologies at University of Siena, Italy  and the Italian non-profit research organization ISOPROG, in collaboration with the Center of Biocomputational … Continue reading Regulation of Cancer Promoting Molecule EphB4 Offers Potential Treatment Target for Mesothelioma, Other Cancers

New Natural Therapeutic Agent to Fight Diabetic Nephropathy

A team of researchers have published in the Journal of  Cellular Physiology that a new natural extract is able to inhibit the development of diabetic nephropathy, a kidney disease that is increasing in incidence throughout the world. "The new extract of natural origin, obtained from red oranges and lemons, is rich in cyanidin 3-glucoside and other polyphenols,” … Continue reading New Natural Therapeutic Agent to Fight Diabetic Nephropathy

Exploiting RB1 Predictive Value for Cancer Therapy in the Clinical Setting: Lost in Translation

Newswise — The RB1 protein, named after the pediatric tumor retinoblastoma, was discovered in the 80s as the first tumor suppressor and, since then, its pathway has been found inactivated in most human cancers. RB1 ability to halt tumor development and growth has been mainly ascribed to its function in cell cycle regulation, which directly … Continue reading Exploiting RB1 Predictive Value for Cancer Therapy in the Clinical Setting: Lost in Translation

Cervical Cancer During Pregnancy, Though Serious, is Highly Treatable According to New Research Review

Newswise — A team of researchers in the Gynecologic Oncology Unit of the University Hospital of Bologna, in collaboration with Professor Antonio Giordano from the Sbarro Health Research Organization, has published a revision of the literature about cases of cervical cancer in pregnancy, with the addition of new cases treated at the University Hospital of … Continue reading Cervical Cancer During Pregnancy, Though Serious, is Highly Treatable According to New Research Review